Product Compliance And Certification For Food Supplement In Japan

Scope and evidence must be confirmed before any paid tests or filings.

“Food supplement” is a commercial description, not one blanket Japanese product approval. Start with the complete formula, dose, presentation, intended audience and every proposed on-pack and online claim. A product may be an ordinary food, fall into a defined health-claim food category, or raise a medicinal classification issue. Separately, imported food, ingredients, manufacturing, safety, advertising and Japanese labeling each have their own checks. A third-party GMP/ISO certificate is not a substitute for the legally applicable route.

Classify the proposed supplement before selecting a claim

First ask what the buyer is being promised, rather than assuming that a capsule, vitamin or “natural” ingredient qualifies for a special status. Make the following five decisions before placing a Japanese label order:

Record every active and inactive ingredient, botanical species/plant part, extraction solvent, additive, daily intake and target consumer; screen for food-versus-medicine issues.
Separate ordinary nutrition statements from specified nutrient-function wording, broader physiological function claims and disease-treatment or prevention claims.
If relying on a nutrient-function claim, identify the precise eligible nutrient, prescribed statement, applicable intake range and required precautions; do not extrapolate to a botanical.
If seeking an FFC claim, identify the functional ingredient, scientific substantiation, eligible healthy population, notifier and whether the product meets the current notification and safety-management requirements.
Check whether special dietary-use representations (e.g. for sick persons or infants) or other product-specific restrictions change the route.

Food–medicine review is fact-specific: Japanese authorities consider composition, form, intended use, presentation and claimed effects together. A treatment claim is a serious stop-and-review signal; its presence does not, by itself, establish that every component has been formally classified as a medicine. Separately, the narrow FOSHU framework may permit specifically authorized disease-risk-reduction wording, which is not a license to promise disease treatment.

Cross-regime route matrix for a Japan launch

Routes below describe claims eligibility, not alternative exemptions from general food safety and labeling duties. FFC = Foods with Function Claims; FNFC = Foods with Nutrient Function Claims; FOSHU = Foods for Specified Health Uses.

Presentation / trigger	Route or dependency	Decision before sale
Food supplement with no regulated function claim	Ordinary food route; food-safety and Japanese labeling rules still apply	Remove implied function or medicine claims; screen ingredients and label.
Permitted nutrient-function wording for eligible nutrient	FNFC: prescribed nutrient, quantitative criteria, prescribed wording and precautions; no individual permit or notification when compliant	Verify nutrient amount for daily intake and all label conditions.
Specific scientifically supported non-disease physiological function	FFC: premarket CAA notification and operator responsibility; not government approval of efficacy or safety	Confirm eligibility, evidence, filing and public disclosure before FFC marketing.
Product-specific health-purpose claim seeking review	FOSHU: individual government examination and permission for the relevant label claim	Do not use FOSHU wording/mark before permission.
Representation for infants, patients or other special dietary uses	Separate Foods for Special Dietary Uses permission may be required for that representation	Check intended user and exact special-use claim.
Therapeutic/preventive disease claim or medicine-only ingredient	Potential pharmaceutical route rather than a food claim category	Stop food launch assumptions and obtain Japanese classification review.

Important route boundary: CAA states that a single food cannot combine two or more Foods with Health Claims systems. FNFC, FFC and FOSHU are not badges that can be stacked on the same SKU. Select and substantiate one applicable health-claims route; ordinary food-safety, import and general labeling duties remain cumulative.

Ingredient, dosage-form and safety checks that can change the route

Physical format and concentration matter. An overseas ingredient certificate or authorization is useful evidence but does not establish Japanese acceptance.

Distinguish food ingredient from food additive and verify Japanese permitted-additive status, compositional specifications and conditions of use; a substance accepted overseas is not automatically accepted in Japan.
For botanical extracts and high-potency tablets/capsules, document identity, extraction, concentration, contaminants, stability and lot reproducibility. Assess whether the FFC manufacturing/processing standards for tablets, capsules and similar foods made with natural extracts apply.
The transition for the strengthened FFC GMP/label provisions ended on 31 August 2026. Do not treat the former transition as an ongoing exemption in October 2026; verify current rules for the exact formulation and facility.
Screen any designated ingredients and applicable adverse-health-event reporting duties; prepare a complaints, investigation, traceability and withdrawal escalation path. These requirements are not confined to an FFC logo.

Current-rule check: the CAA published revised FFC notification guidance on 1 October 2025. The 2026-08-31 transition date concerns specified FFC GMP and revised label provisions, not a universal deadline for every supplement or a product-wide Japanese GMP certificate.

2026 operational and reporting check: CAA published a notifier-facing inspection guideline and checklist dated 1 October 2026 for the FFC manufacturing standards applicable to specified natural-extract tablets and capsules. Compare the real factory evidence with that guidance; it is not a new universal supplement licence, nor is a private GMP certificate a substitute. Reporting of suspected health harm is category-dependent: designated-ingredient foods and FFC/FOSHU can have distinct duties; do not assume every ordinary supplement is subject to identical mandatory reporting.

Imported supplement: customs entry is not marketing permission

For commercial import, the Food Sanitation Act import-notification pathway and the Japanese claims pathway are parallel checks. Neither clears the other.

Before shipment: the Japanese importer should prepare manufacturer, country, complete raw-material/additive, process and food-specification information and consult the competent MHLW quarantine station if classification or sampling is unclear.
At entry: for food imported for sale or business use, file the required import notification with the competent quarantine station; documentary checks and risk-based inspection may follow. A compliant notification outcome allows customs formalities to continue, not automatic permission for all advertising claims.
Before retail: independently clear the current Japanese label, claim pathway, supply-chain responsibilities and any notification/permission specific to the proposed claim. Personal-use import exemptions must not be repurposed for commercial stock.

Japanese label and advertising: five release gates

The Consumer Affairs Agency says food labels for sale in Japan must be in Japanese. Reconcile pack, marketplace listing, website, distributor brochure and influencer brief; translating a foreign-market claim verbatim is not a compliance method.

Gate 1 — legal identity: ingredient names, additives, allergens, origin-related information and importer/business-operator attribution as applicable to the specific food.
Gate 2 — food information: net quantity, storage, expiry/best-before, applicable nutrition declaration and supported nutrient values.
Gate 3 — claim taxonomy: ordinary food must not imitate FNFC, FFC or FOSHU, and no food claim should purport to treat or prevent disease.
Gate 4 — category text: use the prescribed FNFC wording and warnings or the corresponding FFC notification/permission-linked information, as relevant; do not copy a competing product's number or mark.
Gate 5 — evidence-to-copy match: every quantitative, functional and safety statement must match the dossier and product as actually sold, including serving size and target audience.

Product-specific evidence file and change control

Use this SKU release dossier as a working handoff between the foreign factory, Japan importer and local label/claim reviewer. It is a proposed control tool, not a prescribed government application form.

Formula master: ingredient supplier, exact substances and botanical identity, additive purpose, per-unit/per-day dose and alternative raw materials.
Classification memo: food/medicine screening, intended audience, exact Japanese claims and selection/exclusion of FNFC, FFC, FOSHU and special-use pathways.
Safety evidence: specifications, contamination/identity results selected by risk, stability, limits, and designated-ingredient screen.
Manufacturing file: flow chart, site controls, GMP applicability assessment and batch traceability; include FFC natural-extract dosage-form obligations where triggered.
Import record: responsible importer, notification evidence, quarantine queries, inspections and shipment-to-lot matching where importing.
Label file: Japanese artwork, nutrition basis, allergen and origin review, online/ad copy, supporting substantiation and signed release decision.
Change log: formula, dose, supplier, plant, claims, target users or packaging changes trigger reassessment of classification, supporting evidence and relevant filings before reuse.

Three launch patterns: what follows, and what remains unresolved

These examples are decision tests, not determinations for unidentified real products.

Illustrative SKU	Working route	Unresolved question / safe next step
Basic vitamin tablet claiming only an allowed prescribed nutrient function	Investigate FNFC in addition to general food compliance	Does the exact nutrient dose and all mandatory wording meet current limits? Verify, then approve Japanese artwork.
Imported botanical-extract capsule promoted as “supports sleep quality”	Check medicine boundary, possible FFC eligibility, safety and applicable extract-dose-form GMP	Which exact functional ingredient, evidence, population and notification? Do not market as FFC without completed required notification process.
High-strength capsule advertised to “treat arthritis”	Do not assume an ordinary food, FNFC or FFC route	Have the wording, ingredient and dose assessed for pharmaceutical classification; suspend the treatment claim.

Where this page ends and nearby product guides begin

“Food supplement” here is the cross-regime stack for an unclassified Japanese supplement SKU. The closely related guide on dietary supplements treats the broader English market term; the protein powder guide focuses on protein/macro-nutrient formulations and related presentation choices; the general food-product guide addresses non-supplement food matrices and baseline rules. Those topics do not replace this SKU-by-SKU decision tree.

Food supplement Japan: specific FAQs

Is a US/EU supplement certificate enough to sell in Japan?

No. Overseas certificates may support supplier assurance but do not decide Japanese food/drug classification, additive legality, import notification or Japanese health claims.

Does every vitamin capsule require FFC notification?

No. Ordinary-food labeling or FNFC may fit the actual product; FFC is a distinct route for qualifying function claims. Check the exact wording and nutrient criteria first.

Can our importer clear customs before we obtain FOSHU permission?

Food-import notification and claim permission are different controls. A customs step cannot authorize using a FOSHU claim or mark; do not release the affected label before permission.

Does botanical capsule GMP automatically apply to all supplements?

No. Assess the exact regulatory category, natural-extract material and tablet/capsule-like form against current applicable standards; separate mandatory rules from voluntary factory certification.

If we remove an FFC claim, can we keep “improves sleep” on the website?

Not automatically. Promotional function claims can still be regulated; review packaging and all advertising together and remove or substantiate claims only within an eligible legal route.